Company profile SABS
After 38 days of this quarter the interest is at 35.0. Based on that we can calculate that during remaining 53 days it will total up to 84.0. SAB Biotherapeutics expected interest is significantly lower compared to previous quarter (-70.3%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 40 | 118 195.0% QoQ | 95 -19.5% QoQ | 0 -100.0% QoQ |
| 2020 | 257 542.5% YoY inf% QoQ | 404 242.4% YoY 57.2% QoQ | 210 121.1% YoY -48.0% QoQ | 213 inf% YoY 1.4% QoQ |
| 2021 | 200 -22.2% YoY -6.1% QoQ | 112 -72.3% YoY -44.0% QoQ | 196 -6.7% YoY 75.0% QoQ | 430 101.9% YoY 119.4% QoQ |
| 2022 | 258 29.0% YoY -40.0% QoQ | 188 67.9% YoY -27.1% QoQ | 139 -29.1% YoY -26.1% QoQ | 330 -23.3% YoY 137.4% QoQ |
| 2023 | 130 -49.6% YoY -60.6% QoQ | 188 0.0% YoY 44.6% QoQ | 96 -30.9% YoY -48.9% QoQ | 283 -14.2% YoY 194.8% QoQ |
| 2024 | 35 -73.1% YoY -87.6% QoQ | - | - | - |
The average 5 years interest of SAB Biotherapeutics was 15.03 per week. The last year interest of SAB Biotherapeutics compared to the last 5 years has changed by -20.83%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 98.33%.
There is not enough data for SAB Biotherapeutics news to provide analysis
There is not enough data for SAB Biotherapeutics news to provide correlation calculation
There is not enough data for SAB Biotherapeutics news to provide analysis
After 38 days of this quarter the interest is at 41.0. Based on that we can calculate that during remaining 53 days it will total up to 98.0. SAB Biotherapeutics stock price expected interest is significantly lower compared to same quarter last year (-49.5%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 94 | 82 -12.8% QoQ | 95 15.9% QoQ | 137 44.2% QoQ |
| 2020 | 0 -100.0% YoY -100.0% QoQ | 175 113.4% YoY inf% QoQ | 0 -100.0% YoY -100.0% QoQ | 86 -37.2% YoY inf% QoQ |
| 2021 | 67 inf% YoY -22.1% QoQ | 30 -82.9% YoY -55.2% QoQ | 123 inf% YoY 310.0% QoQ | 113 31.4% YoY -8.1% QoQ |
| 2022 | 231 244.8% YoY 104.4% QoQ | 85 183.3% YoY -63.2% QoQ | 163 32.5% YoY 91.8% QoQ | 144 27.4% YoY -11.7% QoQ |
| 2023 | 194 -16.0% YoY 34.7% QoQ | 0 -100.0% YoY -100.0% QoQ | 144 -11.7% YoY inf% QoQ | 83 -42.4% YoY -42.4% QoQ |
| 2024 | 41 -78.9% YoY -50.6% QoQ | - | - | - |
The average 5 years interest of SAB Biotherapeutics stock price was 8.0 per week. The last year interest of SAB Biotherapeutics stock price compared to the last 5 years has changed by -14.88%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -13.25%.
There is not enough data for SAB Biotherapeutics clinical trials to provide analysis
There is not enough data for SAB Biotherapeutics clinical trials to provide correlation calculation
There is not enough data for SAB Biotherapeutics clinical trials to provide analysis
There is not enough data for SAB Biotherapeutics immunotherapies to provide analysis
There is not enough data for SAB Biotherapeutics immunotherapies to provide correlation calculation
There is not enough data for SAB Biotherapeutics immunotherapies to provide analysis
There is not enough data for SAB Biotherapeutics COVID-19 treatment to provide analysis
There is not enough data for SAB Biotherapeutics COVID-19 treatment to provide correlation calculation
There is not enough data for SAB Biotherapeutics COVID-19 treatment to provide analysis
Google Trends for SAB Biotherapeutics influenza treatment
Not enough data for reliable calculations!
There is not enough data for SAB Biotherapeutics influenza treatment to provide analysis
There is not enough data for SAB Biotherapeutics influenza treatment to provide correlation calculation
There is not enough data for SAB Biotherapeutics influenza treatment to provide analysis
Google Trends for SAB Biotherapeutics autoimmune diseases
Not enough data for reliable calculations!
There is not enough data for SAB Biotherapeutics autoimmune diseases to provide analysis
There is not enough data for SAB Biotherapeutics autoimmune diseases to provide correlation calculation
There is not enough data for SAB Biotherapeutics autoimmune diseases to provide analysis
There is not enough data for SAB Biotherapeutics DiversitAb immunotherapy platform to provide analysis
There is not enough data for SAB Biotherapeutics DiversitAb immunotherapy platform to provide correlation calculation
There is not enough data for SAB Biotherapeutics DiversitAb immunotherapy platform to provide analysis
There is not enough data for SAB Biotherapeutics human antibodies to provide analysis
There is not enough data for SAB Biotherapeutics human antibodies to provide correlation calculation
There is not enough data for SAB Biotherapeutics human antibodies to provide analysis